| Name | Title | Contact Details |
|---|
Nipro Diagnostics is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Card Group is a Deer Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM™ can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Developed on the principle that non-invasive cardiac monitoring should provide an excellent quality atrial signal, the CAM is designed to be placed along the sternum—over the heart— to optimize P-wave signal capture. The result is improved ECG resolution, providing more information about the heart rhythm which may lead to more clinically actionable diagnoses.
Rehab Medical is a mobility equipment provider that specializes in Complex Rehab Technology (CRT). CRT is the configuration of mobility equipment that requires custom fitting, design, adjustment, and programming to meet the unique needs of each patient. Rehab Medical strives to improve lives through CRT with its team of experienced assistive technology professionals (ATPs) who utilize innovative technology to help patients regain their independence. Since the company was founded in 2005, Rehab Medical has helped more than 100,000 people regain their independence through wheelchairs and has emerged as a national leader of complex rehab technology within the United States.
Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The Cordella™ Heart Failure System includes a cloud-based disease-management system and a breakthrough implantable wireless pulmonary artery pressure sensor. The seamlessly integrated system enables proactive management and early detection of worsening heart failure, which promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs.